NOT KNOWN DETAILS ABOUT ANARASATAM

This investigation aimed to be familiar with the prospective partnership involving HGF levels and Parkinson’s disease, contributing to the broader comprehension of the disorder’s pathophysiology and probable biomarkers.Dihexa’s molecular framework allows it to cross the blood-brain barrier properly, enabling remarkable bioavailability in comp